Topline Phase 1 data shows generally favorable safety and tolerability profile of AGMB-447 -- -- Pharmacokinetic profile confirms efficient lung restriction with low systemic exposure and high ...

Phase 2b dose ranging data presented at ERS show both doses of AN01 delivered significant and clinically relevant improvements in lung function ...

CRB-913 demonstrated statistically significant and clinically meaningful mean weight loss of 5% at 60 mg after 12 weeks with no plateau ...

Phase 1 single ascending dose study to evaluate the safety, pharmacokinetics, and pharmacodynamics of subcutaneous and intravenous SAB01 in healthy adults ALAMEDA, Calif., Sept. 14, 2026 (GLOBE ...

Two people can take the same dose of the same medicine and have very different results. One may improve, while the other gets ...

Both fractional doses of 17DD yellow fever vaccine were non-inferior to full doses in inducing initial seroconversion. The ...

A breakthrough drug recently approved to treat advanced pancreatic cancer may show promise against lung cancer as well, a new ...

Medical marijuana appears to help cancer patients by decreasing pain, nausea, vomiting, anxiety and depression while also ...

Delgocitinib cream has a significant dose-response relationship for achieving 75% improvement in EASI among patients with AD at 8 weeks.

Research suggests vitamin B12 in both parents may lower birth-defect risk, while folic acid is vital before and during ...

(guvendemir/iStock/Getty Images) You can't change the age written on your ID. But what about the age of your body? A drug ...